Fri Sep 2, 2022 – 10:10 am EDT
This story was originally published by the WND News Center
(WND News Center) – A large study on the impact of using ivermectin as a prophylaxis for COVID-19 found that regular users of the drug experienced up to a 92 percent reduction in mortality compared to those who did not.
Brazilian research scientist Dr. Flavio A. Cadegiani wrote on Twitter that his study in his home country showed a “dose-response effect,” meaning that “the more you used, the more protection you had.”
He observed that people who use ivermectin regularly every 15 days for at least six to eight weeks had up to a 92 percent reduction in mortality.
Cadegiani conducted a previous study of the drug that evaluated whether its use could impact COVID-19 infection and mortality rates.
Last fall, esteemed epidemiologist Dr. Harvey Risch of Yale Medical School was among scientists and physicians who said in Senate testimony that thousands of lives could have been saved if treatments such as ivermectin and hydroxychloroquine had not been suppressed.
In April, after noticing that the word ivermectin was trending on Twitter amid Elon Musk’s move to buy the company, the U.S.
The remainder of this article is available in its entirety at LifeSite News
The views expressed in this news alert by the author do not directly represent that of The Official Street Preachers or its editors